Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6750
Rank
โ‚ฌ0.54 B
Marketcap
27,36ย โ‚ฌ
Share price
-0.08%
Change (1 day)
-9.67%
Change (1 year)

Earnings for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

Earnings in 2025 (TTM): โ‚ฌ24.76 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are โ‚ฌ0.11 Billion. In 2024 the company made an earning of โ‚ฌ19.98 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Avalon Pharma (Middle East Pharmaceutical) from 2024 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ24.76 M23.91%
2024 โ‚ฌ19.98 M